REGiMMUNE Receives $12 Million In Grants To Develop Transplant And ... - Medical News Today (press release) PDF Print

REGiMMUNE Corporation, a privately held biopharmaceutical company focused on developing technologies and products for immune disorders, today announced that ...

read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.